Met Life Investment Management, LLC Medicinova Inc Transaction History

Met Life Investment Management, LLC

$18 Billion
Q4 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 16, 2021	SELL	$5.03 - $6.31 $105,801 - $132,724	-21,034 Closed	0 $0
Q3 2020 Jun 26, 2023	BUY	$4.67 - $11.0 $98,228 - $231,374	21,034 New	21,034 $110,000
Q2 2020 May 24, 2024	BUY	$3.06 - $7.06 $64,364 - $148,500	21,034 New	21,034 $114 Million
Q2 2020 Jun 26, 2023	BUY	$3.06 - $7.06 $64,364 - $148,500	21,034 New	21,034 $114,000
Q2 2020 Mar 22, 2023	BUY	$3.06 - $7.06 $7,331 - $16,915	2,396 Added 12.86%	21,034 $114,000
Q2 2020 Aug 14, 2020	BUY	$3.06 - $7.06 $64,364 - $148,500	21,034 New	21,034 $114,000
Q1 2020 May 15, 2020	SELL	$2.9 - $6.97 $54,050 - $129,906	-18,638 Closed	0 $0
Q4 2019 Jul 12, 2023	BUY	$6.48 - $8.76 $120,774 - $163,268	18,638 New	18,638 $125,000
Q3 2019 Jul 12, 2023	BUY	$7.7 - $10.42 $143,512 - $194,207	18,638 New	18,638 $148,000
Q2 2019 Jul 12, 2023	BUY	$8.29 - $13.22 $154,509 - $246,394	18,638 New	18,638 $179,000
Q1 2019 Jul 13, 2023	BUY	$6.82 - $10.27 $127,111 - $191,412	18,638 New	18,638 $154,000
Q4 2018 Jul 13, 2023	BUY	$7.65 - $12.83 $142,580 - $239,125	18,638 New	18,638 $152,000
Q4 2018 Mar 22, 2023	SELL	$7.65 - $12.83 $78,710 - $132,007	-10,289 Reduced 35.57%	18,638 $152,000
Q4 2018 Feb 14, 2019	SELL	$7.65 - $12.83 $78,710 - $132,007	-10,289 Reduced 35.57%	18,638 $152,000
Q3 2018 Jul 13, 2023	BUY	$7.06 - $12.49 $131,584 - $232,788	18,638 New	18,638 $232,000
Q3 2018 Mar 22, 2023	BUY	$7.06 - $12.49 $204,224 - $361,298	28,927 New	28,927 $361,000
Q3 2018 Nov 14, 2018	BUY	$7.06 - $12.49 $72,640 - $128,509	10,289 Added 55.2%	28,927 $361,000
Q1 2018 May 15, 2018	BUY	$6.6 - $13.91 $123,010 - $259,254	18,638 New	18,638 $190,000

Others Institutions Holding MNOV

# of Institutions

Shares Held

5.13M

Call Options Held

Put Options Held

View Full List

About MEDICINOVA INC

Ticker MNOV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 49,046,200
Market Cap $80.4M
Description
MediciNova, Inc., a biopharmaceutical company, focuses on developing novel and small molecule therapeutics for the treatment of serious diseases with unmet medical needs in the United States. The company is developing MN-166 (ibudilast), an oral anti-inflammatory and neuroprotective agent for treating neurological disorders, such as primary and ...

More about MNOV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Met Life Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Met Life Investment Management, LLC with notifications on news.

Account